In episode 94 of the Immunology Podcast, we chat with Dr. Lili Yang, a Professor of Microbiology, Immunology, and Molecular Genetics at the University of California, Los Angeles. Her research centers on deciphering the molecular mechanisms regulating anti-cancer immune responses, exploiting knowledge to develop novel immunotherapies for treating cancer, and translating these new cancer immunotherapies from bench to bedside. She talks about engineering off-the-shelf immunotherapies to fight cancer and generating CAR-NKT cells from hematopoietic stem and progenitor cells. She also discusses the role of serotonin and how SSRIs can affect cancer therapy efficacy.
Roundup Papers:
4:10 | bit.ly/4gqo2ip
10:38 | bit.ly/3D3QAQg
15:54 | bit.ly/4eKPEgO
27:02 | bit.ly/49oMKxa
40:20 | Guest Interview
#CancerResearch #Immunotherapy #SSRIs
Subscribe today to never miss an episode!
Listen on Apple Podcasts: apple.co/3m9mZbF
Listen on Stitcher: bit.ly/2PHJ2ds
Listen on Spotify: spoti.fi/3hp6Iia
Sign up for episode notifications: bit.ly/3SvveQG
Official Website: immunologypodcast.com/
Enjoy the other episodes in our full series playlist here: bit.ly/3GYuwmm
Find the podcast on social media!
Follow us on X: bit.ly/34LXOYq
Like us on Facebook: bit.ly/36nPEGh
Follow us on LinkedIn: bit.ly/3HY4mkZ
This podcast is brought to you by STEMCELL Technologies!
For a full list of products, as well as educational resources, visit our website: www.stemcell.com